loading
前日終値:
$186.67
開ける:
$186.93
24時間の取引高:
895.67K
Relative Volume:
0.87
時価総額:
$11.62B
収益:
$4.27B
当期純損益:
$-356.15M
株価収益率:
-31.61
EPS:
-5.9702
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
-4.14%
1か月 パフォーマンス:
+13.86%
6か月 パフォーマンス:
+47.39%
1年 パフォーマンス:
+35.80%
1日の値動き範囲:
Value
$184.15
$190.67
1週間の範囲:
Value
$184.15
$198.00
52週間の値動き範囲:
Value
$95.49
$198.00

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1106)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,890
Name
Twitter
@jazzpharma
Name
次回の収益日
2026-02-24
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

Compare JAZZ vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
188.69 11.49B 4.27B -356.15M 1.19B -5.9702
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.89 120.48B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
787.50 81.05B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
749.56 46.33B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.30 42.26B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.02 32.87B 5.36B 287.73M 924.18M 2.5229

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-24 ダウングレード UBS Buy → Neutral
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
Mar 04, 2026

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Mixed Recent Returns And A 5.7% Undervaluation Estimate - simplywall.st

Mar 04, 2026
pulisher
Mar 04, 2026

Insider Sell: Bruce Cozadd Sells 6,000 Shares of Jazz Pharmaceuticals PLC (JAZZ) - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

JAZZ SEC FilingsJazz Pharmaceuticals Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

https://www.msn.com/en-us/money/companies/jazz-pharmaceuticals-plc-jazz-reports-1-2-billion-q4-revenue-beats-1-17b-estimate/ar-AA1Xsvc3?ocid=finance-verthp-feeds - MSN

Mar 04, 2026
pulisher
Mar 04, 2026

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

Jazz Pharmaceuticals plc (JAZZ) Reports $1.2 Billion Q4 Revenue, Beats $1.17B Estimate - Yahoo! Finance Canada

Mar 03, 2026
pulisher
Mar 03, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) lists option-derived shares for sale via Merrill Lynch - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Is Jazz Pharmaceuticals (JAZZ) Still Attractive After A 36% One Year Share Price Jump - simplywall.st

Mar 03, 2026
pulisher
Mar 03, 2026

JAZZ: Record growth, pipeline advances, and rare disease focus drive strong 2026 outlook - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

JAZZ: Record growth, pipeline advances, and new filings drive strong outlook for 2026 - TradingView

Mar 03, 2026
pulisher
Mar 02, 2026

JAZZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells 3,415 Shares - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals Director Sells 3,415 Shares - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) EVP Neena Patil Sells 55,600 Shares - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (JAZZ) director sells 3,415 shares after option exercise - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) CAO Patricia Carr Sells 1,117 Shares - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Insider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) SVP Sells 5,343 Shares of Stock - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Patricia Carr Sells 1,253 Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (JAZZ) CFO granted 11,857 restricted stock units - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (JAZZ) EVP awarded 9,782 restricted stock units in Form 4 - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) grants 14,822 RSUs to R&D leader - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (JAZZ) SVP reports share award and open-market sales - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (JAZZ) CEO receives 44,465 restricted stock units - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (JAZZ) director receives 1,527-share restricted stock unit grant - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals Insider Sold Shares Worth $1,039,134, According to a Recent SEC Filing - marketscreener.com

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) EVP Patil sells 55,600 shares - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (JAZZ) SVP reports RSU grant and tax-driven share sale - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals Reports Record 2025 Revenue, Driven by Xywav Growth - Sleep Review

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unveiling A 17% Upside Potential For Investors - DirectorsTalk Interviews

Mar 02, 2026
pulisher
Mar 02, 2026

Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know - Yahoo Finance

Mar 02, 2026
pulisher
Mar 02, 2026

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing - Yahoo Finance

Mar 02, 2026
pulisher
Mar 01, 2026

Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now? - Insider Monkey

Mar 01, 2026
pulisher
Feb 28, 2026

Jazz Pharmaceuticals (JAZZ) Is Up 10.4% After Record Q4 Revenue And New Oncology Data Release - simplywall.st

Feb 28, 2026
pulisher
Feb 28, 2026

JAZZ Should I Buy - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

Patricia Carr reports JAZZ (NASDAQ: JAZZ) sales of 1,253 and 4,660 shares - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

[144] Jazz Pharmaceuticals plc SEC Filing - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

This Jazz Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga

Feb 27, 2026
pulisher
Feb 27, 2026

JAZZ Receives New Overweight Rating as Barclays Initiates Coverage | JAZZ Stock News - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

Jazz Pharmaceuticals Stock Surges 13% on Oncology Breakthrough: Here’s Where the Stock Could Go in 2026 - TIKR.com

Feb 27, 2026
pulisher
Feb 27, 2026

Jazz Pharmaceuticals' CBD Drug Hits $1B: Time to Buy the Stock? - TradingView

Feb 27, 2026
pulisher
Feb 27, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns Overweight Rating from Analysts at Barclays - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Jazz Pharmaceuticals plc (JAZZ) Jumps Nearly 30% on Strong Q3 and Cancer Drug Trial Progress - Insider Monkey

Feb 27, 2026
pulisher
Feb 26, 2026

Jazz Pharmaceuticals (JAZZ) Quarterly Profit Of US$203 Million Tests Trailing Loss Narrative - simplywall.st

Feb 26, 2026
pulisher
Feb 26, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) Form 144: 10,116 restricted shares; insider sold 2,238 - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Jazz Pharmaceuticals: Relief Rally On 2026 Oxybate Franchise’s Outlook (NASDAQ:JAZZ) - Seeking Alpha

Feb 26, 2026
pulisher
Feb 26, 2026

Fox Run Management L.L.C. Invests $1.37 Million in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Citigroup Inc. - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance - Yahoo Finance

Feb 26, 2026
pulisher
Feb 25, 2026

Jazz Pharmaceuticals stock hits 52-week high at $183.10 By Investing.com - Investing.com Australia

Feb 25, 2026
pulisher
Feb 25, 2026

No-Moat Jazz's Growth Driven by Newly Launched Assets and Pending Expansion of Ziihera - Morningstar

Feb 25, 2026
pulisher
Feb 25, 2026

Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why - Finviz

Feb 25, 2026

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$47.43
price down icon 0.11%
$29.52
price up icon 6.00%
$57.80
price up icon 15.99%
$103.80
price up icon 3.02%
$149.88
price up icon 1.96%
biotechnology ONC
$299.02
price up icon 0.67%
大文字化:     |  ボリューム (24 時間):